142nd APHA Annual Meeting and Exposition

Annual Meeting Recordings are now available for purchase

Implications for human health risk assessment

142nd APHA Annual Meeting and Exposition (November 15 - November 19, 2014): http://www.apha.org/events-and-meetings/annual
Tuesday, November 18, 2014 : 11:30 AM - 11:50 AM

Elaine M. Faustman, PhD DABT , Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA
Human health risk assessment has traditionally involved looking at the potential health effects of environmental contaminants on a chemical-by-chemical basis, or at times, by groups of chemicals.  Current and emerging knowledge about epigenetics, however, may eventually impact the way scientists assess the health risks from environmental exposures.  We now know that we must look at genetic, exposure and regulation across time and within a broader context.  Epigenetics provides this frame yet few examples for its use in risk assessment are available.  Context from Social/Ecological Models can allow us to include neighborhood and Environmental justice issues needed to frame the potential for epigenetics to impact public health and normal development and to differentially impact undeserved communities. This presentation will conclude the session by discussing the potential implications of epigenetics research for human health risk assessment.

Learning Areas:

Environmental health sciences

Learning Objectives:
Describe how to frame and translate epigenetic findings within a risk assessment context.

Keyword(s): Environmental Health, Environmental Justice

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have developed this talk based on my research experience and my review of the literature. I have over 20 years experience.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.